FDA is not the only regulator reading a peptide company's website. The Federal Trade Commission polices the advertising itself, and its standard fits in two sentences that its Health Products Compliance Guidance states outright: advertising must be truthful and not misleading, and before disseminating an ad, advertisers must have adequate substantiation for all objective product claims conveyed, expressly or by implication. For health-related products, the guidance says that substantiation must take the form of competent and reliable scientific evidence.
Every load-bearing word in that standard costs somebody money when they miss it, so it is worth unpacking them one at a time.
Before, not after
Substantiation must exist before the claim runs. A company that publishes first and looks for support when challenged has already violated the standard, whatever the evidence eventually shows. In content terms this means the research file precedes the page, which happens to be the same order this library is written in.
Implied counts as much as express
The guidance covers claims conveyed expressly or by implication, and the FTC's view of what an ad implies is expansive and practical. Product names, imagery, before-and-after framing, category placement, and the surrounding page all convey claims. The guidance also addresses consumer testimonials and expert endorsements directly: an advertiser cannot launder a claim through a customer's mouth, because the testimonial is the advertiser's claim when the advertiser publishes it.
The definition of advertising is equally broad. The guidance applies the term not only to traditional ads but to the variety of marketing techniques and promotion methods a marketer uses, which reaches product pages, blogs, email and social content. A peptide site is, in the FTC's frame, one continuous advertisement.
The same principles, any health product
Most of the guidance's examples involve dietary supplements, and it says plainly that the same legal principles apply to the marketing of any health-related product. There is no research-chemical exemption, no small-company exemption, and no exemption for claims that appear only in a blog post rather than on a product page.
This is the second half of a pincer we described in the research-use article. FDA reads a site's marketing to establish a product's intended use; the FTC reads the same marketing as a set of claims requiring evidence. The same paragraph can create a problem with both agencies at once, which is why content discipline in this category is not a style preference.
What this means for a peptide site, concretely
- Objective claims about what a product or service does, in people, require competent and reliable scientific evidence held in advance. If the evidence does not exist, the claim cannot run anywhere on the site.
- Testimonials and user content are the company's claims once published. Curating enthusiastic customer language about outcomes is publishing outcome claims.
- Business and regulatory content, the kind this library is made of, sits outside the danger zone precisely because it makes claims about documents rather than about bodies, and cites them.
- Substantiation files should be kept, dated, and mapped to the claims they support, the same way our market pages map every number to a state file.
None of this is legal advice, and a company facing a real claims question needs regulatory counsel rather than a marketing article. What a search firm can contribute is structural: content built claims-last and sources-first ranks better, survives audits, and never needs the panicked Friday-afternoon rewrite. In a category this watched, that is not caution. It is strategy.
Frequently asked questions
What does the FTC require for health product claims?
Per its Health Products Compliance Guidance: advertising must be truthful and not misleading, and advertisers must hold adequate substantiation for every objective claim, express or implied, before the ad runs. For health-related products that substantiation must be competent and reliable scientific evidence.
Do FTC advertising rules apply to peptide companies?
Yes. The guidance states that the same legal principles apply to the marketing of any health-related product, and it defines advertising broadly to include the full range of marketing techniques, which reaches product pages, blog content, email and social media, not just paid ads.
Are customer testimonials safe if the company did not write them?
No. The guidance addresses testimonials and endorsements directly: when an advertiser publishes a customer's outcome language, that language becomes the advertiser's own claim and needs the same substantiation. Enthusiasm does not substitute for evidence.
How is the FTC standard different from FDA's concern with marketing?
They read the same pages for different questions. FDA reads marketing to establish a product's intended use, which drives how the product is classified. The FTC reads it as a set of advertising claims requiring prior substantiation. One paragraph can create exposure with both at once.
